Theranostics Market 2023-2028: Revolutionizing Precision Medicine with Radiopharmaceuticals
The Theranostics Market is witnessing remarkable growth, driven by advances in precision medicine and the increasing use of radiopharmaceuticals, especially for cancer and neurological applications. Valued at $2.1 billion in 2023, the market is expected to more than double to $4.3 billion by 2028, registering a robust CAGR of 15.5% during this period, according to the latest MarketsandMarkets™ report.
Download...